iOnctura

company

About

iOnctura is a clinical-stage biotechnology company that specializes in developing treatments for cancer.

Details

Last Funding Type
Series Unknown
Last Funding Money Raised
€15M
Industries
Biotechnology,Health Care,Medical Device,Pharmaceutical
Founded date
Jun 1, 2017
Number Of Employee
11 - 50
Operating Status
Active
Legal Name
iOnctura SA

iOnctura is a biopharmaceutical company focusing on novel therapeutics to modulate key culprits of immunosuppression in the tumor microenvironment. Immune checkpoint inhibitors (eg PD/PD-L1) have shown remarkable effectiveness for some but not for all cancer patients.

The company aims to improve current immune checkpoint therapies by developing novel drugs with potential safety and efficacy profiles that when combined with checkpoint inhibition have the potential to optimize clinical outcomes. Through its partnerships with Merck and Cancer Research Technology (the commercial arm of Cancer Research UK, London, UK), iOnctura has established a pipeline of preclinical molecules to advance towards the clinic in combination with immuno-oncology assets from Merck. iOnctura is supported by a world renowned scientific advisory board and, with its access to CRT’s drug discovery labs and network of academic collaborators, is well-positioned to rapidly establish novel combination therapies in the field of cancer immunology.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
6
€37.60M Fr400K
iOnctura has raised a total of €37.60M Fr400K in funding over 2 rounds. Their latest funding was raised on Dec 20, 2022 from a Series Unknown round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Dec 20, 2022 Series Unknown €15M 1 European Innovation Council Detail
Dec 20, 2022 Grant €2.50M 1 European Innovation Council Detail
Sep 22, 2022 Debt Financing Fr400K 1 FONGIT Innovation Fund Detail
Jul 14, 2020 Series A €5.10M 5 3B Future Health Fund Detail
Jan 23, 2020 Series A €15M 4 Inkef
VI Partners
Detail

Investors

Number of Lead Investors
Number of Investors
6
7
iOnctura is funded by 7 investors. European Innovation Council and FONGIT Innovation Fund are the most recent investors.
Investor Name Lead Investor Funding Round
European Innovation Council Yes Series Unknown
FONGIT Innovation Fund Yes Debt Financing
3B Future Health Fund Yes Series A
Inkef Series A
M Ventures Series A
Schroder Adveq Series A
VI Partners Series A

Employee Profiles

Number of Employee Profiles
6
iOnctura has 6 current employee profiles, including Board member Keno Gutierrez
Board member
Board member
Board member
Executive